Evaluation of Publicly Available Information on Sex-Related Differences in the Efficacy and Safety of Newly Approved Medications
J Gen Intern Med
.
2022 Aug;37(11):2894-2897.
doi: 10.1007/s11606-022-07421-8.
Epub 2022 Feb 8.
Authors
Kyungwan Hong
1
,
Sarah Tanveer
1
,
Hazem E Hassan
2
,
Peter Doshi
3
Affiliations
1
Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, MD, USA.
2
Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, MD, USA.
3
Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, MD, USA. pdoshi@rx.umaryland.edu.
PMID:
35137300
PMCID:
PMC9411330
DOI:
10.1007/s11606-022-07421-8
No abstract available
Publication types
Research Support, U.S. Gov't, P.H.S.
MeSH terms
Drug Approval*
Humans
United States
United States Food and Drug Administration
Grants and funding
U01 FD005946/FD/FDA HHS/United States